Compare Natera Inc. Common Stock (NTRA) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Natera Inc. Common Stock trades at $394 (market cap $57.03B), while Direxion Daily Semiconductor Bear 3X Shares trades at $44.33 (market cap $2.44B). The key difference: Natera Inc. Common Stock is far larger — about 23.4× Direxion Daily Semiconductor Bear 3X Shares's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Direxion Daily Semiconductor Bear 3X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| NTRA | SOXS | |
|---|---|---|
Market Cap | $57.03B | $2.44B |
Volume | 1,131,157 | 88,729,812 |
Sector | Health | Leveraged / Inverse |
52-Week High | $425.64 | $944.00 |
52-Week Low | $179.42 | $29.62 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $56.18B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
SOXS trades at $37.42, up 0.48% with a mixed technical outlook showing bullish overall signals but bearish moving averages. The ETF faces significant volatility as a 3x leveraged inverse semiconductor fund, with recent performance driven by semiconductor sector weakness. Recent news highlights ongoing challenges in the semiconductor space, including Nvidia's China exposure and competitive pressures.
As a tactical inverse ETF, SOXS offers short-term hedging potential against semiconductor declines but carries substantial decay risks for long-term holders. The fund's structure makes it unsuitable for buy-and-hold strategies, with success dependent on accurately timing semiconductor sector downturns amid persistent AI demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
